C A new oral medication to treat patients in the early stages of multiple sclerosis(多发性硬化) has shown considerable promise in two clinical trials. researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S.patients. and potentially the...
A significant proportion of patients newly started on a chronic medication quickly become non-adherent, often intentionally so. Many have problems with their medication and information needs. Patients need more support when starting on new medication for a chronic condition and new services may be ...
Weight gain with Nurtec ODT has not been reported as a side effect in studies looking at its use for either migraine treatment or prevention. In general, Nurtec ODT is well tolerated, with less than 3% of patients reporting a side effect during use. Continue reading What is the mechanism of...
On September 30, 2022, Beijing Peptide Biomedical Technology Co., Ltd. (Bejing Peptide) Semaglutide (ZT001) injection was officially accepted by CDE. Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight manag...
If an HIV treatment doesn't work for you, or you find your medication regimen hard to follow,talk to your doctor. There may be options to consider that are already available. Additionally,you may be able to enroll in a clinical trial. To find one near you, use the search feature oncli...
New measure for medication appropriateness in elderly patientsNo Abstract available for this article.doi:10.1007/BF03271646NoneSpringer International PublishingPharmacoeconomics & Outcomes News Weekly
Also, there were more warfarin patients who had gaps in treatment persistence compared to those prescribed rivaroxaban (8.0% vs 1.1%; P = 0.03). Significant factors affecting medication adherence were age and duration of anticoagulant use. For every 10-year increase in age, MPR increased by 1.7...
by Hospital for Special Surgery In the first such collaboration of its kind, an expert panel of rheumatologists and orthopedic surgeons has developed guidelines for the perioperative management of anti-rheumatic medication in patients undergoing total hip or knee replacement. "Patients with rheumatic ...
A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure frequency in people whose recurrent seizures have been resistant to even the latest medications, new Johns Hopkins-led research suggests. "Many other drugs to...
"These patients live in the face of radical uncertainty about the future—knowing that at some point, the medication could stop working," she said. "Their experience is very different, and far less attention has been paid to them."